Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate
- PMID: 15604447
- DOI: 10.1099/vir.0.80424-0
Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate
Abstract
Group B coxsackieviruses (CVB) cause numerous diseases, including myocarditis, pancreatitis, aseptic meningitis and possibly type 1 diabetes. To date, infectious cDNA copies of CVB type 3 (CVB3) genomes have all been derived from pathogenic virus strains. An infectious cDNA copy of the well-characterized, non-pathogenic CVB3 strain GA genome was cloned in order to facilitate mapping of the CVB genes that influence expression of a virulence phenotype. Comparison of the sequence of the parental CVB3/GA population, derived by direct RT-PCR-mediated sequence analysis, to that of the infectious CVB3/GA progeny genome demonstrated that an authentic copy was cloned; numerous differences were observed in coding and non-coding sequences relative to other CVB3 strains. Progeny CVB3/GA replicated similarly to the parental strain in three different cell cultures and was avirulent when inoculated into mice, causing neither pancreatitis nor myocarditis. Inoculation of mice with CVB3/GA protected mice completely against myocarditis and pancreatitis induced by cardiovirulent CVB3 challenge. The secondary structure predicted for the CVB3/GA domain II, a region within the 5' non-translated region that is implicated as a key site affecting the expression of a cardiovirulent phenotype, differs from those predicted for cardiovirulent and pancreovirulent CVB3 strains. This is the first report characterizing a cloned CVB3 genome from an avirulent strain.
Similar articles
-
An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses.Arch Virol. 1994;135(1-2):115-30. doi: 10.1007/BF01309769. Arch Virol. 1994. PMID: 8198437
-
The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region.J Virol. 1995 Aug;69(8):4607-18. doi: 10.1128/JVI.69.8.4607-4618.1995. J Virol. 1995. PMID: 7609025 Free PMC article.
-
Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice.J Med Virol. 2000 Sep;62(1):70-81. doi: 10.1002/1096-9071(200009)62:1<70::aid-jmv11>3.0.co;2-r. J Med Virol. 2000. PMID: 10935991
-
Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease.Trends Microbiol. 1996 May;4(5):175-9. doi: 10.1016/0966-842x(96)10026-3. Trends Microbiol. 1996. PMID: 8727596 Review.
-
The group B coxsackieviruses and myocarditis.Rev Med Virol. 2001 Nov-Dec;11(6):355-68. doi: 10.1002/rmv.326. Rev Med Virol. 2001. PMID: 11746998 Review.
Cited by
-
Comparative Study of Preparation, Evaluation, and Pharmacokinetics in Beagle Dogs of Curcumin β-Cyclodextrin Inclusion Complex, Curcumin Solid Dispersion, and Curcumin Phospholipid Complex.Molecules. 2022 May 7;27(9):2998. doi: 10.3390/molecules27092998. Molecules. 2022. PMID: 35566349 Free PMC article.
-
Oncolytic activity of a coxsackievirus B3 strain in patient-derived cervical squamous cell carcinoma organoids and synergistic effect with paclitaxel.Virol J. 2024 Oct 5;21(1):245. doi: 10.1186/s12985-024-02502-y. Virol J. 2024. PMID: 39369233 Free PMC article.
-
Enteroviruses, type 1 diabetes and hygiene: a complex relationship.Rev Med Virol. 2010 Mar;20(2):106-16. doi: 10.1002/rmv.639. Rev Med Virol. 2010. PMID: 20049905 Free PMC article. Review.
-
Role of RNA Domain Structure and Orientation in the Coxsackievirus B3 Virulence Phenotype.J Virol. 2023 May 31;97(5):e0044823. doi: 10.1128/jvi.00448-23. Epub 2023 Apr 19. J Virol. 2023. PMID: 37074194 Free PMC article.
-
Role of RNA structure motifs in IRES-dependent translation initiation of the coxsackievirus B3: new insights for developing live-attenuated strains for vaccines and gene therapy.Mol Biotechnol. 2013 Oct;55(2):179-202. doi: 10.1007/s12033-013-9674-4. Mol Biotechnol. 2013. PMID: 23881360 Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources